SANDOZ SITAGLIPTIN

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: d25358d79beb105e
Drug Approval Canada Name: SANDOZ SITAGLIPTIN
Product Name: SANDOZ SITAGLIPTIN
Status: Marketed
Status Date: 2023-01-05
Original Market Date: 2023-01-05
Din: 02504065
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:20.05
Atc Original: A10BH01 SITAGLIPTIN
Atc Name: a 10 bh 01
Aig Number: 0152414001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d25358d79beb105e

Type

Standard